Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Campus
Campus

Atherothrombosis

Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

Science in Atherothrombosis

Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

No Rebound Effect Post Clopidogrel Withdrawal
  • Atherothrombosis

No Rebound Effect Post Clopidogrel Withdrawal

Learn More
Insights and impacts from the TALOS-AMI Trial
  • Atherothrombosis

Insights and impacts from the TALOS-AMI Trial

Learn More
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice
  • Atherothrombosis

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Learn More
In hospital outcomes in young patients with AMI: Results from Gulf Coast
  • Atherothrombosis

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Learn More
Adherence and persistence analysis in patients treated with DAPT
  • Atherothrombosis

Adherence and persistence analysis in patients treated with DAPT

Learn More
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)
  • Atherothrombosis

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Learn More
Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?
  • Atherothrombosis

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Learn More
Single Antiplatelet therapy: Insights on earlier use
  • Atherothrombosis

Single Antiplatelet therapy: Insights on earlier use

Learn More

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

No Rebound Effect Post Clopidogrel Withdrawal
  • Atherothrombosis

No Rebound Effect Post Clopidogrel Withdrawal

Learn More
Insights and impacts from the TALOS-AMI Trial
  • Atherothrombosis

Insights and impacts from the TALOS-AMI Trial

Learn More
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice
  • Atherothrombosis

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Learn More
In hospital outcomes in young patients with AMI: Results from Gulf Coast
  • Atherothrombosis

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Learn More
Adherence and persistence analysis in patients treated with DAPT
  • Atherothrombosis

Adherence and persistence analysis in patients treated with DAPT

Learn More
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)
  • Atherothrombosis

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Learn More
Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?
  • Atherothrombosis

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Learn More
Single Antiplatelet therapy: Insights on earlier use
  • Atherothrombosis

Single Antiplatelet therapy: Insights on earlier use

Learn More